Long Non-Coding RNA Signatures Associated with Ferroptosis Predict Prognosis in Colorectal Cancer
Na Li,Jiangli Shen,Ximin Qiao,Yuan Gao,Hong-Bo Su,Shuai Zhang
DOI: https://doi.org/10.2147/IJGM.S331378
IF: 2.145
2022-01-04
International Journal of General Medicine
Abstract:Na Li, 1 Jiangli Shen, 1 Ximin Qiao, 2 Yuan Gao, 3 Hong-Bo Su, 4 Shuai Zhang 5 1 Department of Anorectal Surgery, Xianyang Central Hospital, Xianyang, Shaanxi Province, People's Republic of China; 2 Dean's Office, Xianyang Central Hospital, Xianyang, Shaanxi Province, People's Republic of China; 3 Surgery Department, Xianyang Central Hospital, Xianyang, Shaanxi Province, People's Republic of China; 4 The Second Ward of the Anorectal Hospital, Xi'an Hospital of TCM, Xi'an, Shaanxi Province, People's Republic of China; 5 Journal Editorial Board, Hebei University of Chinese Medicine, Hebei, People's Republic of China Correspondence: Hong-Bo Su; Shuai Zhang Email ; Background: Currently, colorectal cancer has become a common gastrointestinal malignancy that usually occurs in the colon and rectum, and ferroptosis plays a vital role in the pathology and progression of colorectal tumors. Methods: A total of 627 patients (51 normal and 644 tumor samples) from The Cancer Genome Atlas (TCGA)-COAD and TCGA-READ were included in the study. Lasso and Cox's regression was employed to analyze the characteristic lncRNAs in colorectal cancer samples, and a distinctive prognostic model of ferroptosis-related lncRNAs was established. By analyzing the divergence between the high and low-risk groups of ferroptosis-related lncRNAs, 15 characteristic lncRNAs related to the prognosis of colorectal cancer were evaluated. Kaplan–Meier analysis, operation characteristic curve (ROC), nomogram, and gene set enrichment analyses (GSEA) further confirmed the validity of the characteristic prognostic model with ferroptosis-related lncRNAs. Results: Kaplan–Meier analysis confirmed a high-risk group of ferroptosis-related lncRNA interrelated with a poor prognosis in colorectal cancer. AUC estimates of 1 -, 3 -, and 5-year survival rates for ferroptosis-related lncRNA characteristic models were 0.745, 0.767 and 0.789. GSEA analysis showed that immune and malignancy-related pathways were active in the high-risk score group. In addition, differential analyses of immune function, including Checkpoint, cytolytic, HLA, and T cell co-inhibition, differed significantly betwixt low - and high-risk groups. CD160, TNFRSF18, CD27, PDCD1, CD200R1, ADORA2A, TNFRSF14, LAIR1, CD244, CD40, TNFRSF4, CD70, TNFSF14, TNFRSF25, CD276, HHLA2, VTCN1, LAG3, TNFSF18 , and other immune checkpoints had different expressions betwixt the high- and low-risk group. Conclusion: Fifteen kinds of lncRNAs with different expressions (AP003555.1, AC099850.3, AL031985.3, LINC01857, STPG3-AS1, AL137782.1, AC124067.4, AC012313.5, AC083900.1, AC010973.2, ALMS1-IT1, AC013652.1, AC133540.1, AP006621.2, AC018653.3) were closely associated with poor prognosis of colorectal cancer. These indicators were significantly correlated with the overall survival (OS) rate and could be used as prognostic evaluation criteria. Keywords: colorectal cancer, ferroptosis, lncRNAs, immune infiltration, TCGA Colorectal cancer (CRC) ranks fourth in Global Cancer Epidemic Survey, with mortality of 900,000 per year. Standard treatments include endoscopic and surgical local excision, preoperative radiotherapy, palliative chemotherapy, targeting, and immunization treatment. 1 These new treatment regimens have improved overall survival for patients with colorectal cancer. But unfortunately, most patients already had metastatic carcinomas at the time of diagnosis, and colorectal cancer remains a disease with a high mortality rate. Immune checkpoint inhibitors are used to treat patients with high microsatellite instability (DMR-MSI-H) metastatic colorectal tumors. However, this is not practical for other types of colorectal cancer. The therapeutic effect was undesirable. 2 Systemic chemotherapy usually has minimal efficacy and severe systemic adverse reactions. Immunotherapy and targeted therapies are more effective and less toxic than standard chemotherapy regimens. Studies showed that Iron could both promote the proliferation and death of tumor cells. Reactive oxygen species (ROS) and nuclear factor erythroid 2-related factor 2 ( Nrf2 ) promote the ramification of Iron on the Warburg effect of colorectal tumor cells and even inhibit the sensibility of ferroptosis. Hemoglobin could enhance inflammation and inhibit tumor suppression of the P53 gene, 3 promoting cytotoxicity and ROS, inducing carcinoma cell proliferation. In addition, studies have shown potential pathways of ferroptosis-related lncRNAs, including MAPK signaling pathways, mTOR signaling pathways, and glutathione metabolism pathways. In a separate survey of TCGA-COAD, seven ferroptosis-related lncRNA ch -Abstract Truncated-
medicine, general & internal